Holdings
Decheng Capital LLC
As of Sep 30, 2026, Decheng Capital LLC reported 10 positions worth US$678M. Largest: CG Oncology, Inc., Nuvation Bio Inc. and Aclaris Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| CG Oncology, Inc. | 6.37M | US$452M | no change | Sep 30, 2026 |
| Nuvation Bio Inc. | 26M | US$145M | no change | Sep 30, 2026 |
| Aclaris Therapeutics, Inc. | 4.04M | US$21.3M | no change | Sep 30, 2026 |
| Aardvark Therapeutics, Inc. | 3.92M | US$20.6M | no change | Sep 30, 2026 |
| Upstream Bio, Inc. | 2.72M | US$14.4M | no change | Sep 30, 2026 |
| Arcus Biosciences, Inc. | 425K | US$11M | −39,700 | Sep 30, 2026 |
| Equillium, Inc. | 4.45M | US$7.23M | no change | Sep 30, 2026 |
| Zentalis Pharmaceuticals, Inc. | 1.32M | US$3.67M | no change | Sep 30, 2026 |
| BeyondSpring, Inc. | 3.07M | US$2.36M | −735K | Sep 30, 2026 |
| Pyxis Oncology, Inc. | 327K | US$761K | no change | Sep 30, 2026 |